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funded by bilateral arrangements. 
Articles published in low-IF journals 
were more likely to have LMIC first 
authors than papers published in 
medium-IF and high-IF journals. 
Articles with fewer authors (one to 
three) had a greater proportion of 
LMIC last authorships than did  articles 
with a greater number of authors.
South Africa (147), Thailand (135), 
and Uganda (111) had the most 
publications meeting inclusion criteria. 
Uganda (low income) had 41% of ﬁ rst 
and 14% of last authorships. Thailand 
(upper-middle income) had 79% of 
ﬁ rst and 70% of last authorship, while 
South Africa (upper-middle income) 
had 61% of first and 58% of last 
authorship. 
In our detailed study of long-term 
trends across all journals, we found 
a substantial absolute increase in 
LMIC first and last authorships but 
a decrease in the proportion in both 
positions. Although it is reasonable 
to assume that research competencies 
are transferable, so that an increase 
in capacity through HIV-related 
projects is related to a more general 
increase, our analysis might not be 
representative of trends in other ﬁ elds. 
Other limitations to our methods 
include possible misclassification of 
countries of aﬃ  liation, and the lack of 
assessment of research impact.
The status of first author as the 
researcher who has contributed the 
most in terms of writing and conduct 
of research has been established 
for some time.3 The conventions 
Capacity building in 
longitudinal HIV research
Many international health research 
programmes aspire to the twin goals 
of acquiring new knowledge and 
building research capacity in the 
institutions and workforce of low-
income and middle-income country 
(LMIC) partners. Health research is 
now seen as an essential instrument 
to tackle health inequalities in LMICs,1,2 
and has beneﬁ ted from increases in 
funding and trained personnel, but 
these indicators might not equate to a 
greater ability to do research. 
Authorship of scientific reports 
shows academic contribution3 and 
has been used as a proxy for research 
capacity.4 We undertook a bibliometric 
analysis to measure expanded LMIC 
capacity in HIV research and identify 
correlates of success. We chose HIV 
because global funding for HIV 
research increased six-fold from 
2002 to 20085 and because many key 
questions in HIV can only be addressed 
in LMICs, where the burden of disease 
is highest, particularly in Sub-Saharan 
Africa.
In July 2012, we searched PubMed, 
for articles published in 2000–11 
using the key words ”HIV” AND 
(‘“treatment” or ”prevention”) AND 
the names of World Bank classified 
LMICs6 with an HIV prevalence of at 
least 1% in 2000.7 Inclusion criteria 
were full papers reporting on a cohort 
study or randomised trial, in a LMIC, 
with the outcome HIV acquisition or 
disease progression. 
We calculated the proportions of 
articles with first authorships and 
last (or senior) authorships from 
LMICs. Authors’ country of origin was 
determined by stated affiliations. 
We retrieved ﬁ nancial support from 
acknowledgements. For multicountry 
studies, we identiﬁ ed the region on the 
basis of the majority of participants. 
We obtained Impact Factors (IF; 2009) 
from ISI Web of Science. We restricted 
our analysis to cohort studies and 
randomised trials because these 
methods require a substantial level 
of research capacity. We analysed 
data using STATA 12, with the unit of 
analysis being a published article.
From 13 443 articles returned by 
the online search, 747 met inclusion 
criteria. The number increased from 
15 articles in 2000 to 116 in 2011. We 
identified 6878 authors, a median 
of nine per paper. The research was 
mainly done in Africa (586 [78%] 
articles), followed by east Asia and 
the Pacific (143 [19%]). Primary 
academic partner institutions were 
from North America (45%) or Europe 
(28%), whereas 18% reported no high-
income country partner.  
Overall 50% of first authors, 60% 
of second authors, and 36% of last 
authors were from LMICs. Over time, 
the number of LMIC authors increased 
in all three authorship positions 
(ﬁ gure). As a proportion of all papers, 
the proportion of authorships 
decreased from 60% to 47% in ﬁ rst 
position, from 76% to 53% in second, 
and from 57% to 33% in last position.  
Research done in upper-middle-
income countries was almost twice as 
likely to have LMIC ﬁ rst authorship, 
compared with research from low-
income countries. The difference 
was even greater for last authorships 
(table). Articles with a European 
primary partner were more likely to 
have LMIC first or last author than 
those with a North American partner. 
Research funded by pharmaceutical 
organisations was more likely to have 
LMIC ﬁ rst or last authorship than work 
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Figure: Number and proportion of LMIC authors in ﬁ rst, second, and last position
LMIC=low-income and middle-income countries.
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authorship and publication in lower-
IF journals might have resulted from 
a combination of such factors. The 
decrease over time in the proportion 
of LMIC authorships suggests that 
investment in HIV research exceeded 
the growth in local leadership 
capacity. 
Our analysis shows expanding HIV 
research enterprise in LMICs, while 
suggesting that ongoing efforts are 
required to shift the balance towards 
LMIC leadership, particularly in low-
income countries. 
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suggests that researchers from high-
income countries continue to have a 
prominent role in LMIC research. 
While broadly indicating research 
capacity and leadership, authorship 
decisions might also be influenced 
by the wishes of funding and 
collaborating agencies, individuals’ 
academic drive, and English language 
skills. The association between LMIC 
are less clear for second authorship 
but generally indicate a substantial 
role in multi-author papers. The 
status of last authorship is a more 
recent development and has come 
to represent leadership in scientific 
research.3 Although a lag period is 
anticipated for last authorships, 
the decrease in the proportion of 
authorships found in our analysis 
LMIC ﬁ rst authorship LMIC last authorship
n (%) p value n (%) p value
Income level <0·0001 <0·0001
Low 121 (36%) 55 (17%)
Lower-middle 55 (44%) 31 (25%)
Upper-middle 199 (69%) 181 (63%)
Region research undertaken in <0·0001 <0·0001
Sub-Saharan Africa 253 (43%) 166 (28%)
East Asia and Paciﬁ c 110 (77%) 98 (69%)
Latin America 12 (67%) 3 (17%)
Year 0·313 0·010
2000–2002 28 (60%) 27 (57%)
2003–2005 59 (53%) 42 (38%)
2006–2008 134 (51%) 91 (35%)
2009–2011 154 (47%) 107 (33%)
Number of authors 0·002 <0·0001
1–3 26 (74%) 27 (82%)
4–6 83 (60%) 77 (55%)
7–9 118 (48%) 85 (35%)
10–12 96 (44%) 47 (22%)
≥13 52 (46%) 31 (27%)
Journal impact factor <0·0001 <0·0001
None 97 (72%) 74 (56%)
Low (<3) 103 (55%) 79 (42%)
Medium (3–8) 141 (43%) 85 (26%)
High (>8) 34 (34%) 29 (29%)
Partner region <0·0001 <0·0001
North America 126 (38%) 59 (18%)
Europe or UK 90 (42%) 49 (23%)
East Asia and Paciﬁ c 5 (42%) 6 (50%)
NA 131 (97%) 131 (99%)
Mixed 23 (44%) 22 (42%)
Funding <0·0001 <0·0001
High-income country government 83 (32%) 45 (17%)
LMIC government or none 59 (87%) 52 (76%)
International organisation 4 (57%) 2 (29%)
Philanthropic or not-for-proﬁ t organisation 12 (24%) 10 (20%)
Mixed or other 84 (50%) 43 (2265%)
NA 103 (66%) 92 (60%)
Pharmaceutical 30 (75%) 12 (55%)
NA=no funding information provided in the article. LMIC=low-income and middle-income country. 
Table: Predictors of LMIC ﬁ rst and last position authorship
